| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |